-
Views
-
Cite
Cite
Bhaskar Dasgupta, Frances A. Borg, Nada Hassan, Leslie Alexander, Kevin Barraclough, Brian Bourke, Joan Fulcher, Jane Hollywood, Andrew Hutchings, Pat James, Valerie Kyle, Jennifer Nott, Michael Power, Ash Samanta, on behalf of the BSR and BHPR Standards, Guidelines and Audit Working Group, BSR and BHPR guidelines for the management of giant cell arteritis, Rheumatology, Volume 49, Issue 8, August 2010, Pages 1594–1597, https://doi.org/10.1093/rheumatology/keq039a
- Share Icon Share
Extract
Executive summary
Scope and purpose
GCA is the commonest of all the vasculitides. Visual loss occurs in up to one-fifth of patients, which may be preventable by prompt recognition and treatment [1,2].
The aim of these guidelines is to encourage the prompt diagnosis and management of GCA, with emphasis on the prevention of visual loss. Their scope is to provide evidence-based advice for the assessment and diagnosis of GCA, for initial and further management and for monitoring of disease activity, complications and relapse. This is a summary of the guidelines and the full guideline is available at Rheumatology online.
The guidelines
The recommendations for the guidelines are set out in points 1 to 9.
...
A patient >50 years of age presenting with the following features should raise suspicion of GCA:
...
Examination may show:
...
Laboratory investigations include:
...
Features predictive of ischaemic neuro-ophthalmic complications [3, 4]:
...
...
Comments